SALACIA THERAPEUTICS
Live / Applied — Response to non-final action entered (as of 24 Aug 2026)
What this means for you
Not registered yet, but its 14 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99185289
- Mark type
- Stylized text
- Filed
- 14 May 2025
- Attorney of record
- Chelseaa Larsen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, a drug delivery system comprising water-soluble prodrugs, namely, oral tablets, oral capsules, and oral powders that facilitate the solubility of a wide range of pharmaceuticals; drug carriers for medical use, namely, drug delivery agents consisting of molecules that increase water solubility of compounds for oral delivery of therapeutically active chemical compounds for human use
- Class 042 — Scientific and technological services: Research and development services in the field of water-soluble drug delivery technologies; providing product development in the fields of drug delivery systems, small molecules, peptides, pharmaceuticals, and medicine; providing technological information in the fields of drug delivery systems, small molecules, peptides, pharmaceuticals, and medicine
- Class 045 — Legal and security services: Licensing of technology in the field of pharmaceuticals, medicine, and biotechnology; licensing of chemical reagents and water-soluble pharmaceutical products; licensing of patents and patent applications
Owner
- Salacia Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 24 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Jun 2026 — NON-FINAL ACTION E-MAILED
- 17 Jun 2026 — NON-FINAL ACTION WRITTEN
- 19 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Mar 2026 — NON-FINAL ACTION E-MAILED
- 16 Mar 2026 — NON-FINAL ACTION WRITTEN
- 09 Mar 2026 — ASSIGNED TO EXAMINER
- 27 Sept 2025 — ASSIGNED TO EXAMINER
- 23 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED